Could Low-Dose Ketamine Be a Treatment for ADNP Syndrome in Children?
Low-dose ketamine may be a viable treatment option for symptoms of activity-dependent neuroprotective protein syndrome in children.
Source: psychiatryadvisor.com
Stay updated with breaking news from Behavior Scale Revised. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Low-dose ketamine may be a viable treatment option for symptoms of activity-dependent neuroprotective protein syndrome in children.
Low-dose ketamine may be a viable treatment option for symptoms of activity-dependent neuroprotective protein syndrome in children.